Quantitative relationship of circulating p24 antigen with human immunodeficiency virus (HIV) RNA and specific antibody in HIV-infected subjects receiving antiretroviral therapy. The RV43 Study Group

To better understand the biologic meaning and potential clinical utility of p24 antigen measurements in human immunodeficiency virus (HIV) infection, p24 antigen and antibody and HIV RNA were quantitated in parallel. Specimens (n = 311) were analyzed from 74 participants in a zidovudine treatment st...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of infectious diseases 1995-10, Vol.172 (4), p.1091-1095
Main Authors: Brown, A E, Vahey, M T, Zhou, S Y, Chung, R C, Ruiz, N M, Hofheinz, D, Lane, J R, Mayers, D L
Format: Article
Language:English
Subjects:
Adult
AIDS/HIV
Base Sequence
Blotting, Western
CD4 Lymphocyte Count
Female
HIV Antibodies - blood
HIV Core Protein p24 - blood
HIV Infections - drug therapy
HIV Infections - immunology
Humans
Male
Molecular Sequence Data
RNA, Viral - blood
Statistics as Topic
Zidovudine - therapeutic use
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To better understand the biologic meaning and potential clinical utility of p24 antigen measurements in human immunodeficiency virus (HIV) infection, p24 antigen and antibody and HIV RNA were quantitated in parallel. Specimens (n = 311) were analyzed from 74 participants in a zidovudine treatment study. Parallel antigen and RNA measurements revealed the frequent occurrence of two types of discordant results. First, p24 antigen was often not detected in samples with high antibody levels even when > 10(6) RNA copies/mL were present. Second, in specimens in which p24 antigen was detected, the concentration was greater than expected on the basis of HIV RNA values. These results suggest that optimal use of serum p24 antigen values will require consideration of both specific antibody levels and non-virion associated antigen.
ISSN:0022-1899